{
  "ticker": "VHL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02963326",
  "id": "02963326",
  "pages": 4,
  "price_sensitive": true,
  "date": "20250630",
  "time": "0838",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250630/pdf/06l7htttcrlvdt.pdf",
  "summary": "**Summary of Material Information:**  \n\n- **Contract Expansion with TPAC**:  \n  - Scaled from Arizona pilot to full value-based agreement covering **15,000 Medicare lives** (potential to scale further).  \n  - Revenue streams:  \n    - **Guaranteed PMPM fee** (~US$5 per member per month).  \n    - **RPM reimbursements at ~US$70 PPPM** (30% patient conversion target \u2192 **~US$3M p.a.**).  \n    - **Performance bonuses** tied to CMS quality savings.  \n  - **Term**: 1-year initial + annual renewals (60-day termination notice).  \n  - **Growth potential**: TPAC targeting **100,000 Medicare lives within 3 years**.  \n\n- **Strategic Significance**:  \n  - Second major U.S. partnership in 2025 (follows Evolent/HIPA MSSP).  \n  - Positions Vitasora as a leader in **value-based care solutions** under CMS mandates.  \n\n- **Pipeline Outlook**: Additional contract wins expected in coming months.  \n\n*No capital raising, trading halt, or financials disclosed.*",
  "usage": {
    "prompt_tokens": 2405,
    "completion_tokens": 234,
    "total_tokens": 2639,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-29T22:48:12.183990"
}